Open tender · Japan · Public tender
手術不能かつ既存治療不応の進行・再発固形がん患者に対するオキシフェドリン・スルファサラジンの有効性及び安全性を評価する多施設共同第Ia/Ib相臨床試験（実施計画書番号：EPOC2204)における治験総括報告書作成業務 一式
In EnglishPreparation of clinical trial comprehensive report for a multicenter phase Ia/Ib clinical trial evaluating the efficacy and safety of oxfedrine and sulfasalazine in patients with inoperable and refractory progressive/recurrent solid tumors (Implementation Plan No.: EPOC2204), complete set
国立研究開発法人国立がん研究センター · 東京都
国立研究開発法人国立がん研究センター in Japan is inviting bids for “Preparation of clinical trial comprehensive report for a multicenter phase Ia/Ib clinical trial evaluating the efficacy and safety of oxfedrine and…”. Bids close on 4 November 2026, 11:00 JST. askTender lists every requirement to qualify and checks whether your company meets them.
Key facts
- Procedure
- 一般競争入札
- Published
- 08 Oct 2026
Before you bid, askTender
Everything else is in your askTender account
The requirements to qualify, the eligibility check and the bid documents for this tender are in your askTender account.
- What it takes to qualify: every requirement, in the tender’s own words
- Whether your company qualifies: your profile checked against each requirement, showing what you have, what’s missing and how to close the gap
- The documents to file: a checklist, with draft declarations ready to sign
- A bid partner for any requirement you can’t meet alone
- The tender documents, ready to open
- Alerts for new tenders like this one
Public data: 本サイトは官公需情報ポータルサイトの検索APIを利用しています / This site uses the Kankouju Information Portal (官公需情報ポータルサイト) API — · Sources & licences